Circulating Neoplastic Cells

Subscribe to Selected New Research on Circulating Neoplastic Cells

36 relevant articles (2 outcomes, 0 trials/studies) found for this Disease

Description: Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.

Also Known As:

Neoplastic Cells, Circulating; Cells, Neoplasm Circulating; Circulating Cells, Neoplasm; Cell, Circulating Neoplastic; Cell, Embolic Tumor; Cell, Neoplasm Circulating; Cells, Circulating Neoplastic; Cells, Embolic Tumor; Circulating Neoplastic Cell; Embolic Tumor Cell; Embolisms, Tumor; Neoplasm Circulating Cell; Neoplastic Cell, Circulating; Tumor Cell, Embolic; Tumor Embolism; Tumor Embolisms; Embolic Tumor Cells; Embolism, Tumor; Neoplasm Circulating Cells; Tumor Cells, Embolic

Relationship Network

Disease Context: Research Results

Cells

Circulating Neoplastic Cells: 36

Neoplasms: 415397

Neoplastic Processes: 169

Neoplasm Metastasis: 53578

Circulating Neoplastic Cells: 36

Signs and Symptoms Pathological Conditions

Pathologic Processes: 2442

Neoplastic Processes: 169

Neoplasm Metastasis: 53578

Circulating Neoplastic Cells: 36

Related Diseases

1.	Neoplasms (Cancer)
2.	Melanoma (Melanoma, Malignant)
3.	Hepatocellular Carcinoma (Hepatoma)
4.	Clear Cell Sarcoma
5.	Interstitial Lung Diseases (Interstitial Lung Disease)

Experts

1.	Sato, Naoki: 1 article (07/2006)
2.	Yamaguchi, Hiroki: 1 article (07/2006)
3.	Tanaka, Keiji: 1 article (07/2006)
4.	Dan, Kazuo: 1 article (07/2006)
5.	Takano, Teruo: 1 article (07/2006)
6.	Kosugi, Munenori: 1 article (07/2006)
7.	Ono, Takuya: 1 article (07/2006)
8.	Ueoka, Hiroshi: 1 article (09/2005)
9.	Tabata, Masahiro: 1 article (09/2005)
10.	Tanimoto, Mitsune: 1 article (09/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Circulating Neoplastic Cells:

1.	Muramidase (Lysozyme)IBA 01/01/1982 - "Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration." Order ALL the reference details at left...
2.	Doxorubicin (Adriamycin)FDA LinkGeneric 01/01/1990 - "The authors recommend open surgical biopsy with doxorubicin for 3 consecutive days as a protection against the released circulating neoplastic cells. " Order ALL the reference details at left...
3.	CarbonIBA 01/01/1982 - "Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration." Order ALL the reference details at left...
4.	Acetylmuramyl-Alanyl-IsoglutamineIBA 01/01/1982 - "Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration." Order ALL the reference details at left...
5.	Messenger RNA (mRNA)IBA 05/01/2005 - "RESULTS: Positive rate of NY-ESO-1 mRNA was 27.4% in HCC; it was higher in HCC with tumor embolus of portal vein than in HCC without tumor embolism (40.0% vs. 18.9%). " 03/01/2001 - "Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients." Order ALL the reference details at left...
6.	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/01/1997 - "[Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma]" 07/01/1996 - "Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis." Order ALL the reference details at left...
7.	Interleukin-1beta (Interleukin 1 beta)IBA 06/01/2005 - "In vitro, embolic tumor cells retained higher MT1-MMP and pro-MMP-2 levels in basal conditions and after stimulation with interleukin-1beta and interleukin-6. " Order ALL the reference details at left...
8.	Matrix Metalloproteinase 14 (MT1-MMP)IBA 06/01/2005 - "In vitro, embolic tumor cells retained higher MT1-MMP and pro-MMP-2 levels in basal conditions and after stimulation with interleukin-1beta and interleukin-6. " Order ALL the reference details at left...
9.	Interleukin-6 (Interleukin 6)IBA 06/01/2005 - "In vitro, embolic tumor cells retained higher MT1-MMP and pro-MMP-2 levels in basal conditions and after stimulation with interleukin-1beta and interleukin-6. " Order ALL the reference details at left...
10.	Monophenol Monooxygenase (Tyrosinase)IBA 09/01/2003 - "Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma." Order ALL the reference details at left...

Therapies and Procedures

1.	Pneumonectomy (Lung Volume Reduction) 09/01/1996 - "[Tumor embolism with fatal cerebral infarct in pneumonectomy. " 06/01/1996 - "Tumor embolism to LAD during pneumonectomy. " 03/01/1995 - "We report a case of tumor embolism of the lower right extremity after right pneumonectomy. " 03/01/1995 - "Tumor embolism after pneumonectomy for primary pulmonary neoplasia." 09/10/1979 - "[Massive aortic tumor embolism during pneumonectomy. " Order ALL the reference details at left...
2.	Drug Therapy (Chemotherapy) 07/01/1960 - "Effectiveness of chemotherapy in relation to extravascular invasion by embolic tumor cells." 07/28/2006 - "Successful treatment of primary cardiac lymphoma and pulmonary tumor embolism with chemotherapy." 07/01/2001 - "Complications during preoperative chemotherapy were seen in five patients (tumor embolism and tumor progression in one each, and three with adult respiratory distress syndrome, one of which was fatal). " 11/01/2004 - "Of these patients with recurrence, subsequent resections in 12 patients with local recurrence, transarterial tumor embolism or STI-571 chemotherapies in 3 patients with distant mestastases were performed. " Order ALL the reference details at left...
3.	Hepatectomy 01/01/1983 - "Intraoperative pulmonary tumor embolism occurred during right hepatectomy for primary hepatic carcinoma. " 01/01/1983 - "Intraoperative pulmonary tumor embolism after hepatectomy for liver carcinoma." 05/19/1983 - "The authors report a case of pulmonary tumor embolism during a hepatectomy for hepatoma, leading to a fatal cardiac arrest. " Order ALL the reference details at left...
4.	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/01/2004 - "Intraoperative massive pulmonary tumor embolism from clear cell sarcoma in the retroperitoneum: successful treatment using cardiopulmonary bypass." 06/01/1992 - "A 59-year-old man, who suffered a massive pulmonary tumor embolism during surgery for renal cell carcinoma with vena caval invasion, was treated by emergency pulmonary embolectomy using cardiopulmonary bypass. " Order ALL the reference details at left...
5.	Anesthesia 09/01/1973 - "Fatal tumor embolism during examination under anesthesia." 08/01/1998 - "We gave anesthesia to a patient with a right kidney tumor associated with complete occlusion of the inferior vena cava (IVC) by tumor embolism. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Circulating Neoplastic Cells

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>